SETH SANDESH

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$177,908.15
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of SETH SANDESH

The largest purchase of all time was on 2015-12-14 and amounted to 10500 shares of Relmada Therapeutics, Inc. for $30,728.

Biography of SETH SANDESH

No biography is available at this moment.

2018-12-10PurchaseActinium Pharmaceuticals, Inc.
ATNM
Chairman & CEO
10,000
0.0095%
$0.44$4,372-37.79%
2018-07-17PurchaseActinium Pharmaceuticals, Inc.
ATNM
CEO
10,000
0.0094%
$0.79$7,900-28.76%
2018-04-19PurchaseActinium Pharmaceuticals, Inc.
ATNM
Chairman & CEO
5,000
0.0045%
$0.38$1,900+50%
2017-08-02PurchaseActinium Pharmaceuticals, Inc.
ATNM
Chairman & CEO
33,333
0.0538%
$0.75$25,000-3.28%
2017-06-15PurchaseActinium Pharmaceuticals, Inc.
ATNM
Chairman and CEO
7,500
0.013%
$1.16$8,725-45.52%
2016-12-30PurchaseActinium Pharmaceuticals, Inc.
ATNM
Executive Chairman
5,000
0.0104%
$0.88$4,400+16.57%
2016-12-12PurchaseActinium Pharmaceuticals, Inc.
ATNM
Executive Chairman
5,000
0.0104%
$0.98$4,900+5.15%
2016-04-18PurchaseActinium Pharmaceuticals, Inc.
ATNM
director
13,000
0.0279%
$1.98$25,770-24.62%
2016-04-15PurchaseActinium Pharmaceuticals, Inc.
ATNM
director
7,000
0.0151%
$2.00$14,000-24.62%
2016-04-14PurchaseActinium Pharmaceuticals, Inc.
ATNM
director
10,000
0.0213%
$1.99$19,900-25.37%
2015-12-15PurchaseRelmada Therapeutics, Inc.
RLMD
director
9,500
0.0829%
$3.19$30,313-48.75%
2015-12-14PurchaseRelmada Therapeutics, Inc.
RLMD
director
10,500
0.0897%
$2.93$30,728-45.33%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.